Literature DB >> 16053333

PAMAM dendrimer based macromolecules as improved contrast agents.

Vincent J Venditto1, Celeste Aida S Regino, Martin W Brechbiel.   

Abstract

Dendrimers are an attractive platform for macromolecular imaging due to the presence of multiple terminal groups on the exterior of the molecule. Through application of appropriate metal ion chelates, large numbers of metal ions for imaging (paramagnetic or radioopaque) and therapy (radioactive particle emitters) may be conjugated to the dendrimer in combination with a targeting vector, through classic organic synthetic techniques. Thus, a large amount of these metal ions potentially may be site specifically delivered directly into the body with the dendrimer as the vehicle with the targeting vector directing the modified dendrimer. The development of targeted macromolecular agents with acceptable blood retention times and selective organ uptake then has the potential for various biological applications. A review of comparative studies of dendrimers with various externally appended imaging and targeting agents is presented herein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16053333     DOI: 10.1021/mp050019e

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  22 in total

Review 1.  Nanosystems for simultaneous imaging and drug delivery to T cells.

Authors:  Tarek M Fahmy; Peter M Fong; Jason Park; Todd Constable; W Mark Saltzman
Journal:  AAPS J       Date:  2007-06-08       Impact factor: 4.009

Review 2.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation.

Authors:  Wojciech G Lesniak; Manoj K Mishra; Amar Jyoti; Bindu Balakrishnan; Fan Zhang; Elizabeth Nance; Roberto Romero; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Mol Pharm       Date:  2013-10-30       Impact factor: 4.939

Review 4.  Macromolecular and dendrimer-based magnetic resonance contrast agents.

Authors:  Ambika Bumb; Martin W Brechbiel; Peter Choyke
Journal:  Acta Radiol       Date:  2010-09       Impact factor: 1.990

5.  Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing mice.

Authors:  S Sadekar; A Ray; M Janàt-Amsbury; C M Peterson; H Ghandehari
Journal:  Biomacromolecules       Date:  2010-12-03       Impact factor: 6.988

6.  pH-Sensitive MR Responses Induced by Dendron-Functionalized SPIONs.

Authors:  Indrajit Saha; Kathleen E Chaffee; Chuansong Duanmu; Brooke M Woods; Ashley M Stokes; Laura E Buck; Laura L Walkup; Narsimha Sattenapally; Jodi Huggenvik; Yong Gao; Boyd M Goodson
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2012-12-21       Impact factor: 4.126

Review 7.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

8.  Synthesis and evaluation of nanoglobule-cystamine-(Gd-DO3A), a biodegradable nanosized magnetic resonance contrast agent for dynamic contrast-enhanced magnetic resonance urography.

Authors:  Rongzuo Xu; Todd Lyle Kaneshiro; Eun-Kee Jeong; Dennis L Parker; Zheng-Rong Lu
Journal:  Int J Nanomedicine       Date:  2010-09-20

Review 9.  Gadolinium-based contrast agents for magnetic resonance cancer imaging.

Authors:  Zhuxian Zhou; Zheng-Rong Lu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-10-09

10.  Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers.

Authors:  C Andrew Boswell; Peter K Eck; Celeste A S Regino; Marcelino Bernardo; Karen J Wong; Diane E Milenic; Peter L Choyke; Martin W Brechbiel
Journal:  Mol Pharm       Date:  2008-06-07       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.